000 | 01071 a2200301 4500 | ||
---|---|---|---|
005 | 20250516171513.0 | ||
264 | 0 | _c20131113 | |
008 | 201311s 0 0 eng d | ||
022 | _a1365-2044 | ||
024 | 7 |
_a10.1111/anae.12370 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOglesby, K J | |
245 | 0 | 0 |
_aResidual anaesthesia drugs - silent threat, visible solutions. _h[electronic resource] |
260 |
_bAnaesthesia _cSep 2013 |
||
300 |
_a981-2 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aAnesthesia, Intravenous _xinstrumentation |
650 | 0 | 4 |
_aAnesthetics, Intravenous _xadministration & dosage |
650 | 0 | 4 | _aCatheters |
650 | 0 | 4 |
_aEquipment Contamination _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMedication Errors _xprevention & control |
650 | 0 | 4 |
_aNeuromuscular Blocking Agents _xadministration & dosage |
700 | 1 | _aCook, T M | |
700 | 1 | _aJordan, L | |
773 | 0 |
_tAnaesthesia _gvol. 68 _gno. 9 _gp. 981-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/anae.12370 _zAvailable from publisher's website |
999 |
_c23099125 _d23099125 |